Bonk (BONK) is 333.5× the size of dopameme (DOPAMEME) by market capitalisation. Their daily returns move loosely in opposite directions (correlation -0.47 across 39 shared trading days). DOPAMEME has been the more volatile of the two, at 742% annualised against BONK's 100%.
DOPAMEMEBONK
-0.47over 39 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | DOPAMEME | BONK |
|---|---|---|
| Max drawdown (400d) | -89.0% | -89.7% |
| Risk-adjusted return (90d) | -0.11 | 0.03 |
| Best 30 days (past year) | — | +37.0% |
| Worst 30 days (past year) | — | -51.0% |
Relative strength over 90 days: BONK outperformed DOPAMEME by 78.0% — measured on the DOPAMEME/BONK ratio, so it holds regardless of market direction.